Modified human thymic stromal lymphopoietin

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/24 (2006.01) A61K 31/7088 (2006.01) A61K 38/18 (2006.01) A61K 38/20 (2006.01) A61K 48/00 (2006.01) C07K 14/475 (2006.01) C07K 14/54 (2006.01) C07K 16/22 (2006.01) C07K 16/24 (2006.01) C07K 19/00 (2006.01) C12N 5/10 (2006.01) C12N 15/18 (2006.01) C12N 15/62 (2006.01) C12N 15/63 (2006.01) C12P 21/02 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2454578

Modified, furin resistant human TSLP polypeptides and polynucleotides encoding the modified human TSLP polypeptides are provided. Pharmaceutical compositions, B and T cell activation agents, assays and methods of use are also described.

L'invention concerne des polypeptides TSLP humains modifiés, résistant à la furine, et des polynucléotides codant ces polypeptides. L'invention concerne également des compositions pharmaceutiques, des activateurs de lymphocytes B et T, des tests, et des procédés d'utilisation correspondants.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Modified human thymic stromal lymphopoietin does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Modified human thymic stromal lymphopoietin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modified human thymic stromal lymphopoietin will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1916475

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.